![](https://tracker.live.rns-distribution.com/track.live-rns/5030560_75d1671758db0ed18eba2dbba83793b2.png)
For immediate release | 12 January 2024 |
Gooch & Housego PLC
("G&H" or the "Group")
Posting of Annual Report and Notice of AGM
Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components and systems, announces that its Annual Report and Financial Statements for the year ended 30 September 2023 ("Annual Report") and Notice of the 2024 Annual General Meeting ("AGM") is today being posted to shareholders.
The AGM will be held at 11.00am on 21 February 2024 at the Company's head office, Dowlish Ford, Ilminster, Somerset TA19 0PF.
Gooch & Housego's Annual Report and Notice of AGM are available on the Company's website at http://gandh.com/investors/.
For further information contact:
| | |
Charlie Peppiatt, Chief Executive Officer Chris Jewell, Chief Financial Officer | Gooch & Housego PLC | +44 (0) 1460 256440 |
| | |
Mark Court / Sophie Wills / Abigail Gilchrist | Buchanan | +44 (0) 20 7466 5000 |
| | |
Christopher Baird / David Anderson | Investec Bank plc | +44 (0) 20 7597 5970 |
Notes to editors
Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with manufacturing sites in the UK, USA and China. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.